| Daniel L Davies, DO | |
|
155 Borthwick Ave, Suite 202w, Portsmouth, NH 03801-7156 | |
| (603) 433-8434 | |
| (603) 436-6608 |
| Full Name | Daniel L Davies |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 35 Years |
| Location | 155 Borthwick Ave, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083683833 | NPI | - | NPPES |
| 3082880 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 000317 (Connecticut) | Secondary |
| 207R00000X | Internal Medicine | 13450 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Portsmouth, NH | Home health agency |
| Cornerstone Vna | Rochester, NH | Home health agency |
| Pathways Healthcare Llc | Salem, NH | Home health agency |
| Rockingham Vna And Hospice | Exeter, NH | Home health agency |
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| York Hospital | York, ME | Hospital |
| Wentworth-douglass Hospital | Dover, NH | Hospital |
| Exeter Hospital Inc | Exeter, NH | Hospital |
| Elliot Hospital | Manchester, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Appledore Medical Group Inc | 5698666154 | 89 |
News Archive
National Health Investors, Inc. announced today its normalized Funds From Operations ("FFO") and net income for the three months ended March 31, 2010.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.
Eleven IFPMA member companies are involved in the development of new antibiotics. There are currently 34 antibacterial compounds in development (19 molecules and 15 vaccines). Eight compounds are undergoing the final stages of demonstrating their efficacy, quality, and safety (phase 3 clinical trials)...
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.
› Verified 7 days ago
| Entity Name | Appledore Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720077167 PECOS PAC ID: 5698666154 Enrollment ID: O20040601000165 |
News Archive
National Health Investors, Inc. announced today its normalized Funds From Operations ("FFO") and net income for the three months ended March 31, 2010.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.
Eleven IFPMA member companies are involved in the development of new antibiotics. There are currently 34 antibacterial compounds in development (19 molecules and 15 vaccines). Eight compounds are undergoing the final stages of demonstrating their efficacy, quality, and safety (phase 3 clinical trials)...
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel L Davies, DO 155 Borthwick Ave, Suite 202w, Portsmouth, NH 03801-7156 Ph: (603) 433-8434 | Daniel L Davies, DO 155 Borthwick Ave, Suite 202w, Portsmouth, NH 03801-7156 Ph: (603) 433-8434 |
News Archive
National Health Investors, Inc. announced today its normalized Funds From Operations ("FFO") and net income for the three months ended March 31, 2010.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.
Eleven IFPMA member companies are involved in the development of new antibiotics. There are currently 34 antibacterial compounds in development (19 molecules and 15 vaccines). Eight compounds are undergoing the final stages of demonstrating their efficacy, quality, and safety (phase 3 clinical trials)...
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.
› Verified 7 days ago
Robert Millstein, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Campus Dr, Suite 12, Portsmouth, NH 03801 Phone: 603-422-8208 Fax: 603-422-8219 | |
Mr. Hanad Omar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Avenue, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Thomas P Clairmont Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Borthwick Ave, Suite 205, Portsmouth, NH 03801 Phone: 603-436-6115 Fax: 603-433-5567 | |
Brian Choi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 215-442-5031 | |
Dr. Sucharit Suresh Joshi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433 Fax: 603-427-5115 | |
Dr. Michael Casimir Danielski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 875 Greenland Rd, #c-10, Portsmouth, NH 03801 Phone: 603-436-3433 Fax: 603-427-5115 |